Zurueck zur Suche

Reporte zur Charge N014945

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

1Reporte angezeigt
0Todesfaelle
1Hospitalisiert
0Lebensbedrohlich
1Bleibende Schaeden
LA 1

VAERS 857405

MERCK & CO. INC. · HEP A (VAQTA) · Charge N014945

schwer
Staat
LA
Alter
14,0
Geschlecht
F
Eingang
06.09.2022
Impfdatum
03.02.2018
Beginn
06.03.2019
Tage bis Beginn
396,0
Dosis
1
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: unbekannt Erholt: nein
Arthralgia Autonomic nervous system imbalance Constipation Cytogenetic analysis Electrocardiogram Electrocardiogram ambulatory Electroencephalogram Implantable cardiac monitor insertion Laboratory test Pain in extremity Postural orthostatic tachycardia syndrome Sinus tachycardia Syncope Thyroid function test

Symptomtext

POTS; Dysautonomia; syncope; constipation; Arm/Shoulder/Joint pain; Sinus tachycardia; Information has been received from a consumer via the Administration (# 857405) on 17-AUG-2022, regarding a 14-year-old non-pregnant female patient (also reported as male, inconsistent information). The patient's concurrent conditions included asthma. Previous drug reactions, or allergies reported were bee venom (also reported as honey bee, inconsistent information) and strawberries. On 03-FEB-2018 at 15:00 (also reported as 15:36, inconsistent information), the patient was vaccinated with hpv rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) intramuscular (strength, dose, frequency, anatomical location, indication, lot number, and expiration date were not provided) indicated as prophylaxis. On the same fay, the patient was vaccinated with 1 dose of hepatitis A vaccine, inactivated (VAQTA)(also reported as hep a (HAVRIX), inconsistent information) intramuscular in the right arm (lot number N014945 has been verified to be a valid lot number, expiry date 17-JUN-2019) also indicated as prophylaxis. On 06-MAR-2019 (also reported as 06-APR-2019, inconsistent information), the patient experienced POTS (postural orthostatic tachycardia syndrome), dysautonomia (autonomic nervous system imbalance), syncope, constipation, arm/shoulder/joint pain (arthralgia), and sinus tachycardia (hospitalization and disability criteria for ). Additional laboratory and diagnostical tests were performed: electrocardiogram (EKG), electroencephalogram (EEG), Holter Monitor 1 week; "Holter monitor" 30 days; medtronic LOOP monitor implant in chest wall; full laboratory panels, thyroid panels, genetics review and counseling to rule out potential for anything else that could have contributed. The outcome of the aforementioned events was reported as not recovered. The causality assessment was not provided. Follow-up information has been received via telephone call to the physician office on 01-SEP-202 An unspecified reporter, stated that they could not help without a name and date of birth of the patient. The reporter was unable to find a healthcare provider who was completed the adverse event report. Additional information was not expected, all scheduled correspondence was canceled.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Allergy to venom; Asthma; Hypersensitivity
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-